Tumor heterogeneity and cancer stem cell paradigm: Updates in concept, controversies and clinical relevance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor heterogeneity and cancer stem cell paradigm: Updates in concept, controversies and clinical relevance

Published:2014-03-04 Issue:9 Volume:136 Page:1991-2000
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Singh Anup Kumar¹,Arya Rakesh Kumar¹,Maheshwari Shrankhla¹²,Singh Akhilesh¹,Meena Sanjeev¹,Pandey Priyanka³,Dormond Olivier⁴,Datta Dipak¹²

Affiliation:

1. Biochemistry Division; CSIR-Central Drug Research Institute; Lucknow India

2. Academy of Scientific and Innovative Research; New Delhi India

3. National Institute of Biomedical Genomics; Kalyani West Bengal India

4. Department of Visceral Surgery; Centre Hospitalier Universitaire Vaudois and University of Lausanne; Switzerland

Funder

Council of Scientific and Industrial Research

Ministry of Earth Sciences

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference103 articles.

1. Biological diversity in metastatic neoplasms: origins and implications;Fidler;Science,1982

2. Tumor heterogeneity;Heppner;Cancer Res,1984

3. Tumor heterogeneity: causes and consequences;Marusyk;Biochim Biophys Acta,2010

4. The clonal evolution of tumor cell populations;Nowell;Science,1976

5. A decade of exploring the cancer epigenome - biological and translational implications;Baylin;Nat Rev Cancer,2011

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Membrane Partitioning of TEMPO Discriminates Human Lung Cancer from Neighboring Normal Cells;Acta Naturae;2024-01-17

2. LncRNA FOXD1-AS1 regulates pancreatic cancer stem cell properties and 5-FU resistance by regulating the miR-570-3p/SPP1 axis as a ceRNA;Cancer Cell International;2024-01-02

3. Circumventing challenges in mitochondrial targeting for cancer treatment: leveraging nanoplatforms for effective solutions;Materials Advances;2024

4. miRNA-381 regulates renal cancer stem cell properties and sunitinib resistance via targeting SOX4;Biochemistry and Biophysics Reports;2023-12

5. Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR;Journal of Experimental & Clinical Cancer Research;2023-11-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3